Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo

Experimental Cell Research

Volumn 283, Issue 2, 2003, Pages 230-236

  Cattaneo, Maria Grazia ^a   Pola, Sandra ^a   Francescato, Pierangelo ^b   Chillemi, Francesco ^b   Vicentini, Lucia Maria ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Endostatin; Endostatin derived peptides; Human endothelial cells; In vitro angiogenesis; In vivo angiogenesis

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN; PEPTIDE;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL;

EID: 0037442551     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00057-5     Document Type: Article

References (17)

1. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin An endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285.
2. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma . Cell. 79:1994;315-328.
3. Cao Y. Endogenous angiogenesis inhibitors and their therapeutic implications. Int. J. Biochem. Cell B. 33:2001;357-369.
4. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52:1973;2745-2756.
5. Passaniti A., Taylor R.M., Pili R., Guo Y., Long P.V., Haney J.A., Pauly R.R., Grant D.S., Martin G.R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67:1992;519-528.
6. Albini A., Fontanini G., Masiello L., Tacchetti C., Bigini D., Luzzi P., Noonan D.M., Stetler-Stevenson W.G. Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV1-tat product Inhibition of KS-like lesions by TIMP-2 . AIDS. 8:1994;1237-1244.
7. Yamaguchi N., Anand-Apte B., Lee M., Sasaki T., Fukai N., Shapiro R., Que I., Lowik C., Timpl R., Olsen B.R. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 18:1999;4414-4423.
8. Hohenester E., Sasaki T., Olsen B.R., Timpl T. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution. EMBO J. 17:1998;1656-1664.
9. Ding Y.-H., Javaherian K., Lo K.-M., Chopra R., Boehm T., Panciotti J., Harris B.A., Li Y., Shapiro R., Hohenester E., Timpl R., Folkman J., Wiley D.C. Zinc-dependent dimers observed in crystals of human endostatin. Proc. Natl. Acad. Sci. USA. 95:1998;10443-10448.
10. Boehm T., O'Reilly M.S., Keough K., Shiloach J., Shapiro R., Folkman J. Zinc-binding of endostatin is essential for its antiangiogenic activity. Biochem. Biophys. Res. Commun. 252:1998;190-194.
11. Karumanchi S.A., Jha V., Ramchandran R., Karihaloo A., Tsiokas L., Chan B., Dhanabal M., Hanai J.-I., Venkataraman G., Shriver Z., Keiser N., Kalluri R., Zeng H., Mukhopadhyay D., Chen R.L., Lander A.D., Hagihara K., Yamaguchi Y., Sasisekharan R., Cantley L., Sukhatme V.P. Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell. 7:2001;811-822.
12. Shichiri M., Hirata Y. Antiangiogenesis signals by endostatin. FASEB J. 15:2001;1044-1053.
13. Rehn M., Veikkola T., Kukk-Valdre E., Nakamura H., Ilmonen M., Lombardo C.R., Pihlajaniemi T., Alitalo K., Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA. 98:2001;1024-1029.
14. MacDonald N.J., Shivers W.Y., Narum D.L., Plum S.M., Wingard J.N., Fuhrmann S.R., Liang H., Holland-Linn J., Chen D.H.T., Sim B.K.L. Endostatin binds tropomyosin - A potential modulator of the antitumor activity of endostatin. J. Biol. Chem. 276:2001;25190-25196.
15. Kim Y.-M., Jang J.-W., Lee O.-H., Yeon J., Choi E.-Y., Kim K.-W., Lee S.-T., Kwon Y.-G. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2. Cancer Res. 60:2000;5410-5413.
16. Wickström S.A., Veikkola T., Rehn M., Pihlajaniemi T., Alitalo K., Keski-Oja J. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res. 61:2001;6511-6516.
17. Kim Y.-M., Hwang S., Kim Y.-M., Pyun B.-J., Kim T.-Y., Lee S.-T., Gho Y.S., Kwon Y.-G. Endostatin blocks vascular endothelial growth factor-mediated signalling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277:2002;27872-27879.